KRRO – korro bio, inc. (US:NASDAQ)
Stock Stats
News
Korro to Participate in Upcoming Investor Conferences
Korro Receives Australian HREC Approval and CTN Clearance to Initiate Phase 1/2a Clinical Study (REWRITE) of KRRO-110 for Alpha-1 Antitrypsin Deficiency
Korro to Present at the Jefferies London Healthcare Conference
Korro Bio, Inc. (NASDAQ: KRRO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $115.00 price target on the stock.
Korro Bio, Inc. (NASDAQ: KRRO) had its "outperform" rating re-affirmed by analysts at William Blair.
Form 424B3 Korro Bio, Inc.
Form 424B3 Korro Bio, Inc.
Form 8-K Korro Bio, Inc. For: Nov 21
Form SC 13G/A Korro Bio, Inc. Filed by: Point72 Asset Management, L.P.
Form SC 13G/A Korro Bio, Inc. Filed by: Cormorant Asset Management, LP
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.